Suppression of innate and adaptive B cell activation pathways by antibody coengagement of FcγRIIb and CD19. [electronic resource]
Producer: 20150212Description: 991-9 p. digitalISSN:- 1942-0870
- Adult
- Aged
- Antibodies, Monoclonal -- immunology
- Antigens, CD19
- B-Lymphocytes -- immunology
- Cell Proliferation -- drug effects
- Cytokines -- immunology
- Female
- Humans
- Immunity, Innate -- drug effects
- Immunoglobulin G -- immunology
- Immunosuppressive Agents -- immunology
- Lymphocyte Activation -- drug effects
- MAP Kinase Signaling System -- drug effects
- Male
- Middle Aged
- Receptors, Antigen, B-Cell -- immunology
- Receptors, IgG -- antagonists & inhibitors
- Toll-Like Receptor 9 -- antagonists & inhibitors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.